Related Experiment Video
Updated: Apr 21, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
SWI/SNF proteins as targets in cancer therapy
Santiago Schiaffino-Ortega1, Carlos Balinas2, Marta Cuadros3,4
1GENyO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, Granada, Spain. santiago.schiaffino@genyo.es.
Abstract:
Recent identification of synthetic lethal interactions involving several proteins of the SWI/SNF complex discussed in this Research Highlight has opened the possibility of new cancer therapeutic approaches.
Insights
Synthetic lethal interactions involving SWI/SNF complex proteins offer new cancer treatment strategies. This research highlights potential therapeutic avenues by targeting these specific interactions for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The SWI/SNF complex is crucial for chromatin remodeling and gene regulation.
- Dysregulation of SWI/SNF components is implicated in various cancers.
- Understanding SWI/SNF complex functions is vital for developing targeted cancer therapies.
Purpose of the Study:
- To explore synthetic lethal interactions involving SWI/SNF complex proteins.
- To identify potential therapeutic targets within the SWI/SNF pathway for cancer treatment.
- To evaluate the feasibility of targeting these interactions for novel cancer therapies.
Main Methods:
- Review of recent literature on SWI/SNF complex and synthetic lethality.
- Analysis of identified synthetic lethal interactions.
- Discussion of potential therapeutic strategies based on these interactions.
Main Results:
- Several synthetic lethal interactions involving SWI/SNF complex proteins have been identified.
- These interactions present opportunities for targeted cancer therapy.
- The findings suggest a new direction for developing precision oncology treatments.
Conclusions:
- Synthetic lethality involving SWI/SNF proteins provides a promising basis for new cancer therapeutics.
- Targeting these interactions could lead to effective and specific cancer treatments.
- Further research into these interactions may unlock novel therapeutic approaches.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Abnormal Proliferation
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
mTOR Signaling and Cancer Progression